🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the real-world efficacy and safety...
Status
Completed
Location
PekingUMCH
Start Date
2019-09-24
Trial ID
NCT04217967
Treatments Being Tested
This phase II trial studies how well ixazomib citrate and rituximab work in...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2016-05-19
Trial ID
NCT02339922
Treatments Being Tested
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
Study design: Randomised, controlled, multi-centre, open-label, phase III t...
Status
Recruiting
Location
Aberdeen Royal Infirmary
Start Date
2017-03-20
Trial ID
NCT03562169
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
This study will determine the safety profile, tolerability, and maximum tol...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-10-12
Trial ID
NCT00932698
Treatments Being Tested
The purpose of this study is to characterize the single-dose pharmacokineti...
Status
Completed
Location
Winship Cancer Institute, Emory University
Start Date
2013-09-16
Trial ID
NCT01830816
Treatments Being Tested
This study is an open-label, multicenter, phase 1, dose-escalation study of...
Status
Completed
Location
Tower Cancer Research Center
Start Date
2009-08
Trial ID
NCT00893464
Treatments Being Tested
This research study is evaluating a new drug called "ixazomib" as a possibl...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10
Trial ID
NCT02916771
Treatments Being Tested
The purpose of this study is to determine whether the addition of oral ixaz...
Status
Completed
Location
University of Arkansas Medical Sciences
Start Date
2012-08-01
Trial ID
NCT01564537
Treatments Being Tested